InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Weber Kathleen Gallagher, Chairman & CEO. Director active across 2 companies, notably Orasure Technologies INC. Cumulatively, 4 disclosures have been recorded. Activity tracked since 5 January 2022. The latest transaction was filed on 1 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
1,467 shares@ US$8.860.0056% mcap2.5% of flowCommon StockSEC:0001593968-22-000406
1,467 shares@ US$8.860.0056% mcap2.5% of flowCommon StockSEC:0001593968-22-000406:0
60,901 shares@ US$8.210.21% mcap97.5% of flowCommon StockSEC:0001593968-22-000180
60,901 shares@ US$8.210.21% mcap97.5% of flowCommon StockSEC:0001593968-22-000180:0
4 of 4 declarations
About Weber Kathleen Gallagher
Kathleen Gallagher Weber is the President of Molecular Solutions at ORASURE TECHNOLOGIES INC. She leads the company's strategic initiatives and oversees its operations. Her expertise in the healthcare sector is essential for developing innovative solutions.
